MedTrace Logo

Q-Trial in Patients With Hepatitis C

NCT01438320 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2015-03-20

No results posted yet for this study

Summary

The goal of this study is to translate laboratory findings that Quercetin, a bioflavonoid, is safe and has antiviral activity in people with hepatitis C.

Conditions

  • Chronic Hepatitis C

Interventions

DIETARY_SUPPLEMENT

Quercetin

Bioflavonoid

Sponsors & Collaborators

Principal Investigators

  • Samuel W French, MD/PhD · University of California, Los Angeles

  • Nu Lu, M.D. · University of California, Los Angeles

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438320 on ClinicalTrials.gov